NeuroSense Therapeutics L... (NRSN)
NASDAQ: NRSN
· Real-Time Price · USD
2.48
0.10 (4.20%)
At close: Jun 16, 2025, 3:59 PM
2.42
-2.52%
After-hours: Jun 16, 2025, 07:23 PM EDT
4.20% (1D)
| Bid | 2.35 |
| Market Cap | 59.55M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.21M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -4.6 |
| Forward PE | -11.9 |
| Analyst | Hold |
| Ask | 2.6 |
| Volume | 285,625 |
| Avg. Volume (20D) | 245,288 |
| Open | 2.36 |
| Previous Close | 2.38 |
| Day's Range | 2.21 - 2.50 |
| 52-Week Range | 0.51 - 2.60 |
| Beta | 1.60 |
About NRSN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRSN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRSN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+12.28%
NeuroSense Therapeutics shares are trading higher....
Unlock content with
Pro Subscription
6 months ago
+14.27%
NeuroSense Therapeutics shares are trading higher after the company announced its CEO purchased $5 million worth of ordinary shares in a private placement.
